News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Vincent Rajkumar: Introducing a one-stop site to estimate risk of progression in myeloma.
Photo of Vincent Rajkumar from healthtree.org
Sep 16, 2023, 17:55

Vincent Rajkumar: Introducing a one-stop site to estimate risk of progression in myeloma.

Vincent Rajkumar, Editor-in-Chief at Blood Cancer Journal, recently shared on X/Twitter:

“MyelomaRisk.com
Introducing a one-stop site to estimate risk of progression in myeloma, SMM, MGUS. Bookmark it!
Link to the website and an alternate link.

Source: Vincent Rajkumar/Twitter

cancer E. Amadou Touré Myeloma OncoDaily Oncology Shaji Kumar Vincent Rajkumar
Special Coverage
Career
Dec 24, 2024, 12:28
OncoInfluencers to Follow on Social Media: Fadi Haddad
Science
Dec 24, 2024, 12:16
Five papers suggested by Arndt Vogel
Blog
Dec 24, 2024, 12:09
Personalized Cancer Therapy: The Role of Individualized Neoantigen Therapy
Science
Dec 24, 2024, 11:44
Erman Akkus: Pancreatic Cancer - Year in review
Blog
Dec 24, 2024, 11:40
Joshua Brody: Practice-changing ASH24 updates on Follicular Lymphoma Immunotherapy
Blog
Dec 24, 2024, 11:36
How T-cells recognize foreign proteins has changed the way we think about the immune response
Blog
Dec 24, 2024, 11:33
Muhammad Umair Mushtaq: Utilizing CAR-T therapy in relapsed/refractory multiple myeloma
Science
Dec 24, 2024, 11:31
Breakthrough of solid tumor treatment: CAR-NK immunotherapy, review by Hung Trinh
Insight
Dec 24, 2024, 11:28
Jack Huang: Strategies of Combination Immunotherapies in Cancer
Science
Dec 24, 2024, 11:24
Long term natural history of Branch Duct Intraductal Papillary Mucinous Neoplasm beyond 10 years of follow-up
Science
Dec 24, 2024, 11:20
Impact of Financial Toxicity on Treatment Adherence and QOL in Pancreatic Cancer
Blog
Dec 24, 2024, 11:09
Erman Akkus: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma